Health status of patients with Autoimmune Liver Disease during SARS-CoV-2 outbreak in northern Italy

During the pandemic caused by the novel Coronavirus SARS-CoV-2 disease (COVID-19) questions arise on risk of patients with autoimmune conditions under immunosuppressive drugs (IS). There is a mounting evidence that severe COVID-19 is characterized by an imbalanced multi-system immune-inflammatory response to the pathogen by the host, and acknowledged risk factors for poorer outcome are older age and preexisting non-respiratory chronic pro-inflammatory conditions such as obesity, hypertension, diabetes and cardiovascular disease (1).
Source: Journal of Hepatology - Category: Gastroenterology Authors: Tags: Letter to the Editor Source Type: research

Related Links:

Publication date: September 2020Source: American Heart Journal, Volume 227Author(s): Payam Dehghani, Laura J. Davidson, Cindy L. Grines, Keshav Nayak, Jacqueline Saw, Prashant Kaul, Akshay Bagai, Ross Garberich, Christian Schmidt, Hung Q. Ly, Jay Giri, Perwaiz Meraj, Binita Shah, Santiago Garcia, Scott Sharkey, David A. Wood, Frederick G. Welt, Ehtisham Mahmud, Timothy D. Henry
Source: American Heart Journal - Category: Cardiology Source Type: research
Source: Canadian Journal of Anesthesia - Category: Anesthesiology Source Type: research
Source: Canadian Journal of Anesthesia - Category: Anesthesiology Source Type: research
Source: Canadian Journal of Anesthesia - Category: Anesthesiology Source Type: research
Source: Canadian Journal of Anesthesia - Category: Anesthesiology Source Type: research
Authors: Kim S, Jin HJ, Kim SR PMID: 32638569 [PubMed]
Source: Allergy, Asthma and Immunology Research - Category: Allergy & Immunology Tags: Allergy Asthma Immunol Res Source Type: research
We report this consensus to support allergists and clinical immunologists to make optimal decisions under the urgent situation in Asia. PMID: 32638559 [PubMed]
Source: Allergy, Asthma and Immunology Research - Category: Allergy & Immunology Tags: Allergy Asthma Immunol Res Source Type: research
Publication date: Available online 9 July 2020Source: Clinica Chimica ActaAuthor(s): Verena Haselmann, Maximilian Kittel, Catharina Gerhards, Margot Thiaucourt, Romy Eichner, Victor Costina, Michael Neumaier
Source: Clinica Chimica Acta - Category: Laboratory Medicine Source Type: research
Authors: Naik R, Peden K Abstract Developing traditional viral vaccines for infectious diseases usually takes years, as these are usually produced either by chemical inactivation of the virus or attenuation of the pathogen, processes that can take considerable time to validate and also require the live pathogen. With the advent of nucleic-acid vaccines (DNA and mRNA), the time to vaccine design and production is considerably shortened, since once the platform has been established, all that is required is the sequence of the antigen gene, its synthesis and insertion into an appropriate expression vector; importantly...
Source: Current Topics in Microbiology and Immunology - Category: Microbiology Tags: Curr Top Microbiol Immunol Source Type: research
Conclusions: As policymakers face the very difficult question of the necessity and effectiveness of social distancing across the U.S., counties where the policies have been imposed have effectively increased social distancing and have seen slowing the spread of COVID-19. These results might help policymakers to make the public understand the risks and benefits of the lockdown. PMID: 32636878 [PubMed]
Source: Pan American Journal of Public Health - Category: International Medicine & Public Health Tags: Rev Panam Salud Publica Source Type: research
More News: Autoimmune Disease | Cardiology | Cardiovascular | Coronavirus | COVID-19 | Diabetes | Eating Disorders & Weight Management | Endocrinology | Gastroenterology | Heart | Hypertension | Italy Health | Liver | Liver Disease | Obesity | Outbreaks | Pandemics | Respiratory Medicine | SARS | Urology & Nephrology